Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBFR3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,412
Award facts
- Contract value 100% obligated
- $14,412.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Dupixent 300 mg/2 ml pens with a ceiling value of $14,412.08. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 1, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, making this a critical pharmaceutical supply for military and federal healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's Medical Supply Chain, providing an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FBFR3?
SPE2DR26FBFR3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FBFR3 worth?
The government has obligated $14,412 on SPE2DR26FBFR3.
Is contract SPE2DR26FBFR3 an order under another contract?
Yes. SPE2DR26FBFR3 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBFR3 competed?
The extent of competition for SPE2DR26FBFR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award